ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,103 | -48.3% | 8,612 | -33.7% | 0.00% | – |
| Q2 2023 | $100,756 | -47.5% | 12,984 | -63.9% | 0.00% | – |
| Q1 2022 | $192,000 | -66.0% | 35,968 | -6.4% | 0.00% | -100.0% |
| Q4 2021 | $565,000 | -25.9% | 38,428 | +5.4% | 0.00% | 0.0% |
| Q3 2021 | $762,000 | +5.8% | 36,443 | -10.4% | 0.00% | 0.0% |
| Q2 2021 | $720,000 | -13.8% | 40,685 | +19.3% | 0.00% | 0.0% |
| Q1 2021 | $835,000 | -26.5% | 34,089 | +1.6% | 0.00% | -50.0% |
| Q4 2020 | $1,136,000 | +246.3% | 33,559 | +155.6% | 0.00% | +100.0% |
| Q3 2020 | $328,000 | -26.0% | 13,129 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $443,000 | – | 13,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $116,820,000 | 11.19% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $14,756,000 | 9.10% |
| Euclidean Capital LLC | 996,734 | $24,420,000 | 8.17% |
| Invus Financial Advisors, LLC | 1,007,575 | $24,686,000 | 5.66% |
| EcoR1 Capital, LLC | 3,092,218 | $75,759,000 | 3.36% |
| Ally Bridge Group (NY) LLC | 413,061 | $10,120,000 | 1.94% |
| EMERALD ADVISERS, LLC | 615,511 | $15,080,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $57,271,000 | 0.54% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 624,210 | $15,293,000 | 0.51% |
| Casdin Capital, LLC | 601,515 | $14,737,000 | 0.44% |